Evidence map›Paper›PMID 28701402›Full record

ArticleJournal of virology2017

Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.

Willy M J M Bogers, Susan W Barnett, Herman Oostermeijer, Ivonne G Nieuwenhuis, Niels Beenhakker, Daniella Mortier, Petra Mooij, Gerrit Koopman, Edmund Remarque, Gregoire Martin and 10 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 4 countries.

Willy M J M BogersDepartment of Virology, Biomedical Primate Research Centre (BPRC), Rijswijk, The Netherlands bogers@bprc.nl jlh66@cam.ac.uk.
Susan W BarnettNovartis Vaccines and Diagnostics Corporation, Emeryville, California, USA.
Herman OostermeijerDepartment of Virology, Biomedical Primate Research Centre (BPRC), Rijswijk, The Netherlands.
Ivonne G NieuwenhuisDepartment of Virology, Biomedical Primate Research Centre (BPRC), Rijswijk, The Netherlands.
Niels BeenhakkerDepartment of Virology, Biomedical Primate Research Centre (BPRC), Rijswijk, The Netherlands.
Daniella MortierDepartment of Virology, Biomedical Primate Research Centre (BPRC), Rijswijk, The Netherlands.
Petra MooijDepartment of Virology, Biomedical Primate Research Centre (BPRC), Rijswijk, The Netherlands.
Gerrit KoopmanDepartment of Virology, Biomedical Primate Research Centre (BPRC), Rijswijk, The Netherlands.
Edmund RemarqueDepartment of Virology, Biomedical Primate Research Centre (BPRC), Rijswijk, The Netherlands.
Gregoire MartinCEA, Joliot, Service d'Ingénierie Moléculaire des Protéines, Gif sur Yvette, France.
Rachel Pei-Jen LaiLaboratory of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Antu K DeyNovartis Vaccines and Diagnostics Corporation, Emeryville, California, USA.
Yide SunNovartis Vaccines and Diagnostics Corporation, Emeryville, California, USA.
Brian BurkeNovartis Vaccines and Diagnostics Corporation, Emeryville, California, USA.
Guido FerrariDuke University Medical Center, Durham, North Carolina, USA.
David MontefioriDuke University Medical Center, Durham, North Carolina, USA.
Loic MartinCEA, Joliot, Service d'Ingénierie Moléculaire des Protéines, Gif sur Yvette, France.
David DavisDepartment of Virology, Biomedical Primate Research Centre (BPRC), Rijswijk, The Netherlands.
Indresh SrivastavaNovartis Vaccines and Diagnostics Corporation, Emeryville, California, USA.
Jonathan L HeeneyLaboratory of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom bogers@bprc.nl jlh66@cam.ac.uk.
Biomedical Primate Research Centre · NLNovartis (United States) · USCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRDuke Medical Center · USUniversity of Cambridge · GB

Funding

Vaccine TechnologiesP01AI066287 · NIAID · NOVARTIS VACCINES AND DIAGNOSTICS, INC. · PI DAVIS, DAVID · 2006 to 2010
$21.3M
NIAID NIH HHS P01 AI066287Wellcome TrustWellcome Trust 083844/Z/07/Z
6 · The paper itself

Abstract

Strategies are needed to improve the immunogenicity of HIV-1 envelope (Env) antigens (Ag) for more long-lived, efficacious HIV-1 vaccine-induced B-cell responses. HIV-1 Env gp140 (native or uncleaved molecules) or gp120 monomeric proteins elicit relatively poor B-cell responses which are short-lived. We hypothesized that Env engagement of the CD4 receptor on T-helper cells results in anergic effects on T-cell recruitment and consequently a lack of strong, robust, and durable B-memory responses. To test this hypothesis, we occluded the CD4 binding site (CD4bs) of gp140 by stable cross-linking with a 3-kDa CD4 miniprotein mimetic, serving to block ligation of gp140 on CD4

Indexed as

AIDS VaccinesAnimalsAntibodies, NeutralizingAntibody-Dependent Cell CytotoxicityBinding Sites, AntibodyB-LymphocytesCD4 Antigensenv Gene Products, Human Immunodeficiency VirusHIV-1HIV AntibodiesMacaca mulattaT-Lymphocytes, Helper-InducerVaccinationAIDS VaccinesAntibodies, NeutralizingCD4 Antigensenv Gene Products, Human Immunodeficiency Virusgp140 envelope protein, Human immunodeficiency virus 1HIV AntibodiesB-cell responsesCD4 mimeticCD4 occludedhuman immunodeficiency virusnonhuman primatesT-cell responsesvaccines

Identifiers

PMID28701402
PMCPMC5599767
OpenAlexW2735935634

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.